Patents by Inventor Dubravko Jelic

Dubravko Jelic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrolides with Anti-Inflammatory Activity
    Publication number: 20120058963
    Abstract: The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4? position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-?, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation.
    Type: Application
    Filed: November 15, 2011
    Publication date: March 8, 2012
    Applicant: Glaxo Group Limited
    Inventors: Sulejman Alihodzic, Martina Bosnar, Ognjen Culic, Vesna Erakovic Haber, Antun Hutinec, Dubravko Jelic, Goran Kragol, Nikola Marjanovic, Zorica Marusic-Istuk, Marija Ribic, Vanja Vela
  • Macrolides with anti-inflammatory activity
    Patent number: 8080529
    Abstract: The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4? position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-?, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: December 20, 2011
    Assignee: Glaxo Group Limited
    Inventors: Sulejman Alihodzic, Martina Bosnar, Ognjen Culic, Vesna Erakovic Haber, Antun Hutinec, Dubravko Jelic, Goran Kragol, Nikola Marjanovic, Zorica Marusic-Istuk, Marija Ribic, Vanja Vela
  • Macrolides With Anti-Inflammatory Activity
    Publication number: 20080221046
    Abstract: The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4? position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-?, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation.
    Type: Application
    Filed: January 13, 2006
    Publication date: September 11, 2008
    Inventors: Ognjen Culic, Martina Bosnar, Nikola Marjanovic, Dubravko Jelic, Sulejman Alihodzic, Vanja Vela, Zorica Marusic-Istuk, Vesna Erakovic, Berislav Bosnjak, Boska Hrvacic, Marija Tomaskovic, Vanesa Munic, Vanesa Ivetic, Antun Hutinec, Goran Kragol, Marija Leljak
  • 9A-Carbamoyl and Thiocarbamoyl Azalides with Anti-Inflammatory Activity
    Publication number: 20080200403
    Abstract: The use of semi-synthetic 9a-carbamoyl or thiocarbamoyl azalides for the treatment and prevention of inflammatory diseases and conditions in humans and animals. More particularly, the invention relates to the use of 15-membered azalides having at the 9a-position carbamoyl or thiocarbamoyl group, and their pharmaceutically acceptable derivatives for the treatment and prevention of inflammatory diseases and conditions in humans and animals.
    Type: Application
    Filed: January 13, 2006
    Publication date: August 21, 2008
    Inventors: Ognjen Culic, Martina Bosnar, Nikola Marjanovic, Vesna Erakovic, Dubravko Jelic, Donatella Verbanac